Although as histone readers in the SWI/SNF complex, the bromodomain in BRG1 or Brm has been intensively studied as a module that binds selected acetyl-lysine on histones42,43, the potent acetyl-lysine-competitive inhibitors failed to display any antiproliferative phenotype in many cancer cell lines43. The gene discussed is SMARCA2; the disease is cancer.